We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Court Rules Against Apotex in Generic Prilosec Cases
Court Rules Against Apotex in Generic Prilosec Cases
February 17, 2006
Generic drugmaker Apotex has lost its bid to market a 40-mg version of AstraZeneca’s $1.7 billion heartburn drug Prilosec, after a federal court ruled against Apotex in its lawsuit against the FDA.